Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- ~ Pergamon 0306-4522(95)00241-3 Printed in Great Britain 0306-4522/95 $9.50 + 0.00
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- The Reinforcing Effects of Ethanol Within the Nucleus Accumbens Shell Involve Activation of Local GABA and Serotonin Receptors
- Cloning and Characterization of the Rat 5-Htzb Receptor
- Print This Article
- 5-HT2A Receptor-Stimulated Phosphoinositide Hydrolysis in the Stimulus Effects of Hallucinogens
- Reduced Signal Transduction by 5-HT4 Receptors After Long-Term Venlafaxine Treatment
- Known Bioactive Library: Tocriscreen Mini Library 2
- Methylenedioxymethamph
- Wo 2007/044693 A2
- Two Members of a Distinct Subfamily of 5-Hydroxytryptamine Receptors Differentially Expressed in Rat Brain MARK G
- Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: a Narrative Review of the Experimental Evidence
- S-Mephedrone: Preclinical Investigation of a Synthetic Cathinone Against Behavioral and Neurochemical Effects of Cocaine and Mdpv
- LOCALISATION and MODULATION of Gabab and 5-HT3
- 1410315111.Full.Pdf
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- (MDMA) by (± )-MDMA Neurotoxicity: Protection by Fluoxetine
- Tepzz 5 58¥Zb T
- Table of Contents
- HHS Public Access Author Manuscript
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Method of Treating Functional Bowel Disorders
- (12) United States Patent (10) Patent N0.2 US 8,178,524 B2
- Chapter 3 Drug Treatment for Anxiety Disorders
- 5-HT1F): a Fifth 5-HT1 Receptor Subtype Coupled to the Inhibition of Adenylate Cyclase NIKA ADHAM, HUNG-TEH Kao*, LEE E
- MDMA: Further Evidence That Its Action in the Medial Prefrontal Cortex Is Mediated by the Serotonergic System
- A Three-Choice Drug Discrimination Procedure Differentiates the Stimulus Effects of D-Amphetamine and MDMA
- United States Patent (19) 11 Patent Number: 5,922,341 Smith Et Al
- Monograph Series
- The Marketing of 5-Hydroxytryptamine: Depression Or Anxiety?
- (12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Methylenedioxymethamphetamine Lee E
- PKA Regulatory Subunit 1A Inactivating Mutation Induces Serotonin Signaling in Primary Pigmented Nodular Adrenal Disease